Option Care Health, Inc. · NASDAQ:OPCH

Option Care Health — Investor Presentation (August 2026)

20 slides from Option Care Health's investor presentation, August 2026

  1. Slide 1: Extraordinary Care That Changes Lives

    Extraordinary Care That Changes Lives Option Care Health, Inc. August 2026 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | August 2026

  2. Slide 2: Disclaimers

    Disclaimers Forward-Looking Statements This presentation may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “pla

  3. Slide 3: Our purpose and mission

    Our purpose Provide extraordinary care that changes lives. Our mission Transform healthcare by providing innovative services that improve outcomes, reduce overall costs of care, and deliver hope for patients and families. © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | Au

  4. Slide 4: Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services

    Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services National Scale with Local Responsiveness 315,000+ o Resilient full-service Patients Served in 2025 network that supports a broad set 5,000+ of clinical services Multidisciplinary Clinicians across a var

  5. Slide 5: Recognized for Generating Measurable Positive Impact and Driving Meaningful Change

    Recognized for Generating Measurable Positive Impact and Driving Meaningful Change #15 TIME’s World’s Most Impactful Companies 2026 “This recognition reflects the meaningful impact our team members make every day. We never lose sight of the fact that behind every dose dispensed and every nursing vis

  6. Slide 6: On the Right Side of Healthcare: Meeting Needs to Capture Growing Demand at Scale

    On the Right Side of Healthcare Meeting Needs to Capture Growing Demand at Scale 1 o U.S. Home Infusion industry projected to grow high single Home Infusion Landscape digit % annually, driven by therapy growth, cost pressures & patient preference including ‘aging in place’ trends Option Care $100B H

  7. Slide 7: Secular and Industry Trends Driving Toward Lower-Cost Home and Alternate Site Care

    Secular and Industry Trends Driving Toward Lower- Cost Home and Alternate Site Care Policy & Shifting Patient Site-of-Care Pharmaceutical Technology & Reimbursement Demographics Preference Innovation Data Evolution Landscape • Aging population • Higher-acuity • Expansion of • Greater use of • Ongoin

  8. Slide 8: Durable and Resilient Portfolio

    Durable and Resilient Portfolio Therapies, Pharma Programs & Payer Partnerships 2.5 million+ 315,000+ Infusions administered in 2025 Patients Served in 2025 600+ Therapies served in 2025, including limited 92% distribution drugs and pharma programs Overall Patient Satisfaction 87% 2026 YTD revenue f

  9. Slide 9: Diversified Revenue & Gross Profit Mix Drives Sustainable Growth

    Diversified Revenue & Gross Profit Mix Drives Sustainable Growth1 Revenue Mix Gross Profit Mix o Branded therapies represent ~50% of revenue but <20% of gross profit Biosimilar Generic o Gross profit composed Biosimilar primarily of multisource generic & biosimilar Generic therapies Branded o Expand

  10. Slide 10: 2026 Priorities

    2026 Priorities o Taking decisive actions to reaccelerate revenue growth trajectory and drive greater long-term value creation o Near-term capital allocation reprioritization, focusing on internal investments for profitable growth and share repurchases o Focused on rebuilding momentum from reset thr

  11. Slide 11: Q2 2026 Financial Performance

    Q2 2026 Financial Performance Revenue Growth Highlights ($ in millions except EPS) o Revenue +7% sequential / +2% YoY o Acute: High single-digit growth vs. PY o Continue to outperform industry growth o Chronic: Revenue in line with PY, sequential growth $1,416 $1,442 o Strong growth in IG/Neuro and

  12. Slide 12: Full-Year 2026 Guidance & Key Assumptions

    Full-Year 2026 Guidance & Key Assumptions FY ’26 Guidance Update Guidance Key Assumptions + Growth vs. PY1 o Net Revenue $5.675B to $5.775B, +1% o FY ’26 o Approx. (-600bps) total company Net Revenue growth headwind from CID o Adj. Diluted EPS $1.85 to $1.92, +10% o (-$55M) GP$ headwind from CID, to

  13. Slide 13: Strong Record of Revenue Growth & Operating Leverage

    Strong Record of Revenue Growth & Operating Leverage Revenue Adj. EBITDA + Margin +13% $5.65B $471M +16% CAGR CAGR $3.0B $222M 7.3% 8.3% 2020 2025 2020 2025 Demonstrated Ability to Execute and Deliver on Growth Commitments © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | A

  14. Slide 14: Strategic Capital Deployment Balancing Growth & Return to Shareholders

    Strategic Capital Deployment Balancing Growth & Return to Shareholders Strategic Capital Deployment | ’21 –’26 YTD ~$1.6B $200M Operating Cash Flow | ’21 – ’26 YTD CapEx Strong and consistent cash generation profile $1.5B $303M >$1.0B 2.1x M&A deployed since ’21 $975M Liquidity1 Net Debt Leverage Ra

  15. Slide 15: Compelling Investment Proposition

    Compelling Investment Proposition Shifts Toward Cost- National Scale with Diversified, Resilient Effective Home & Local Responsiveness Portfolio of Therapies & Alternate Site Care Models Pharma Programs Longstanding Payer Track Record of Double- Proven, Experienced Partnerships with 96% Digit Growth

  16. Slide 16: Contact Us

    Contact Us Our Website investors@optioncarehealth.com optioncarehealth.com © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Investor Presentation | August 2026 16

  17. Slide 17: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures OPTION CARE HEALTH, INC. QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Net income $ 53,913 $ 50,523 $ 99,256 $ 97,265 Intere

  18. Slide 18: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures OPTION CARE HEALTH, INC. QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) For historical reconciliations of non-GAAP financial measures, please see our SEC filings and other financial reports, which ar

  19. Slide 19: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures OPTION CARE HEALTH, INC. RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES (IN THOUSANDS)(UNAUDITED) Year Ended December 31, 2025 2020 Net income (loss) $ 207,585 $ (8,076) Interest expense, net 54,558 107,770 Income tax expense 75,315 2,833 Depreciation and amort

  20. Slide 20: Reconciliation to Non-GAAP Measures

    Reconciliation to Non-GAAP Measures OPTION CARE HEALTH, INC. RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES (IN THOUSANDS)(UNAUDITED) Trailing Twelve Months June 30, 2026 Net income (loss) $ 209,576 Interest expense, net 54,204 Income tax expense 75,897 Depreciation and amortization expense 71,40

Option Care Health — Investor Presentation (August 2026) on 6ix